CH5.L vs. 500G.L
CH5.L (Amundi ETF MSCI Europe Healthcare UCITS ETF) and 500G.L (Amundi S&P 500 Swap UCITS ETF USD Acc) are both exchange-traded funds - CH5.L is a Health & Biotech Equities fund tracking the MSCI World/Health Care NR USD, while 500G.L is a S&P 500 fund tracking the S&P 500. Both are passively managed. Over the past 10 years, CH5.L returned -3.17%/yr vs 16.24%/yr for 500G.L. At a 0.49 correlation, their price movements are largely independent. CH5.L charges 0.25%/yr vs 0.15%/yr for 500G.L.
Performance
CH5.L vs. 500G.L - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CH5.L achieves a -3.01% return, which is significantly lower than 500G.L's 10.57% return. Over the past 10 years, CH5.L has underperformed 500G.L with an annualized return of -3.17%, while 500G.L has yielded a comparatively higher 16.24% annualized return.
CH5.L
- 1D
- 3.21%
- 1M
- 0.27%
- YTD
- -3.01%
- 6M
- -1.85%
- 1Y
- 7.49%
- 3Y*
- -26.49%
- 5Y*
- -13.43%
- 10Y*
- -3.17%
500G.L
- 1D
- -0.04%
- 1M
- 4.53%
- YTD
- 10.57%
- 6M
- 9.87%
- 1Y
- 29.10%
- 3Y*
- 19.12%
- 5Y*
- 15.05%
- 10Y*
- 16.24%
CH5.L vs. 500G.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
CH5.L Amundi ETF MSCI Europe Healthcare UCITS ETF | -3.01% | 11.85% | -63.23% | 5.38% | 1.64% | 17.03% | 3.58% | 24.30% | 0.41% | 6.87% |
500G.L Amundi S&P 500 Swap UCITS ETF USD Acc | 10.57% | 9.44% | 27.44% | 19.89% | -8.86% | 31.35% | 13.81% | 27.01% | 0.05% | 10.79% |
Correlation
The correlation between CH5.L and 500G.L is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.19 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.27 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.34 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.49 |
Correlation (All Time) Calculated using the full available price history since Feb 24, 2016 | 0.49 |
Over the past year, the correlation between CH5.L and 500G.L has dropped to 0.19 - well below their long-term average of 0.49, suggesting their price drivers have been diverging.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CH5.L vs. 500G.L — Risk / Return Rank
CH5.L
500G.L
CH5.L vs. 500G.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amundi ETF MSCI Europe Healthcare UCITS ETF (CH5.L) and Amundi S&P 500 Swap UCITS ETF USD Acc (500G.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| CH5.L | 500G.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.26 | ||
| Sortino ratioReturn per unit of downside risk | -2.77 | ||
| Omega ratioGain probability vs. loss probability | 1.10 | 1.51 | -0.42 |
| Calmar ratioReturn relative to maximum drawdown | 0.60 | 4.08 | -3.49 |
| Martin ratioReturn relative to average drawdown | 1.43 | 15.27 | -13.84 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| CH5.L | 500G.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.49 | 2.76 | -2.26 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.42 | 1.05 | -1.47 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | -0.13 | 1.05 | -1.18 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.02 | 1.07 | -1.05 |
Drawdowns
CH5.L vs. 500G.L - Drawdown Comparison
The maximum CH5.L drawdown since its inception was -70.04%, which is greater than 500G.L's maximum drawdown of -25.52%. Use the drawdown chart below to compare losses from any high point for CH5.L and 500G.L.
Loading charts...
Drawdown Indicators
| CH5.L | 500G.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -70.04% | -25.52% | -44.52% |
Max Drawdown (1Y)Largest decline over 1 year | -13.44% | -7.12% | -6.32% |
Max Drawdown (3Y)Largest decline over 3 years | -70.04% | -21.12% | -48.92% |
Max Drawdown (5Y)Largest decline over 5 years | -70.04% | -21.12% | -48.92% |
Max Drawdown (10Y)Largest decline over 10 years | -70.04% | -25.52% | -44.52% |
Current DrawdownCurrent decline from peak | -64.16% | -0.22% | -63.94% |
Average DrawdownAverage peak-to-trough decline | -14.80% | -3.29% | -11.51% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.61% | 1.91% | +3.70% |
Volatility
CH5.L vs. 500G.L - Volatility Comparison
Amundi ETF MSCI Europe Healthcare UCITS ETF (CH5.L) has a higher volatility of 5.66% compared to Amundi S&P 500 Swap UCITS ETF USD Acc (500G.L) at 2.65%. This indicates that CH5.L's price experiences larger fluctuations and is considered to be riskier than 500G.L based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CH5.L | 500G.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.66% | 2.65% | +3.01% |
Volatility (6M)Calculated over the trailing 6-month period | 11.79% | 7.13% | +4.66% |
Volatility (1Y)Calculated over the trailing 1-year period | 16.28% | 10.55% | +5.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 31.85% | 14.31% | +17.54% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 25.28% | 15.54% | +9.74% |
CH5.L vs. 500G.L - Expense Ratio Comparison
CH5.L has a 0.25% expense ratio, which is higher than 500G.L's 0.15% expense ratio. However, both funds are considered low-cost compared to the broader market, where average expense ratios usually range from 0.3% to 0.9%.
Dividends
CH5.L vs. 500G.L - Dividend Comparison
Neither CH5.L nor 500G.L has paid dividends to shareholders.
Frequently Asked Questions
CH5.L and 500G.L have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, 500G.L is cheaper at 0.15% per year. The better choice depends on whether you care most about return, fees, risk, or income.
500G.L is cheaper with a 0.15% expense ratio, compared with 0.25% for CH5.L.
CH5.L is categorized as Health & Biotech Equities, while 500G.L is S&P 500. CH5.L tracks MSCI World/Health Care NR USD, while 500G.L tracks S&P 500. Their fees differ too: 0.25% for CH5.L and 0.15% for 500G.L.
Find the right allocation for CH5.L and 500G.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer